User profiles for Julio C. Rojas
Julio C. RojasEl Colegio de la Frontera Sur Verified email at ecosur.mx Cited by 3884 |
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration
With the potential development of new disease-modifying Alzheimer’s disease (AD) therapies,
simple, widely available screening tests are needed to identify which individuals, who are …
simple, widely available screening tests are needed to identify which individuals, who are …
Low-level light therapy of the eye and brain
JC Rojas, F Gonzalez-Lima - Eye and brain, 2011 - Taylor & Francis
Low-level light therapy (LLLT) using red to near-infrared light energy has gained attention in
recent years as a new scientific approach with therapeutic applications in ophthalmology, …
recent years as a new scientific approach with therapeutic applications in ophthalmology, …
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis
…, OT Pyykkö, O Ragnarsson, JC Rojas… - JAMA …, 2019 - jamanetwork.com
Importance Neurofilament light protein (NfL) is elevated in cerebrospinal fluid (CSF) of a
number of neurological conditions compared with healthy controls (HC) and is a candidate …
number of neurological conditions compared with healthy controls (HC) and is a candidate …
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
…, C Baufeld, MW Wood, C Sutphen, L McCue, C Xiong… - Nature, 2017 - nature.com
APOE4 is the strongest genetic risk factor for late-onset Alzheimer disease. ApoE4 increases
brain amyloid-β pathology relative to other ApoE isoforms 1 . However, whether APOE …
brain amyloid-β pathology relative to other ApoE isoforms 1 . However, whether APOE …
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic …
…, CE Teunissen, GD Rabinovici, JC Rojas… - The Lancet …, 2021 - thelancet.com
Background Plasma tau phosphorylated at threonine 217 (p-tau217) and plasma tau
phosphorylated at threonine 181 (p-tau181) are associated with Alzheimer's disease tau pathology. …
phosphorylated at threonine 181 (p-tau181) are associated with Alzheimer's disease tau pathology. …
Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET
…, DC Perry, JP O'Neil, J Pham, JC Rojas… - Science translational …, 2020 - science.org
β-Amyloid plaques and tau-containing neurofibrillary tangles are the two neuropathological
hallmarks of Alzheimer’s disease (AD) and are thought to play crucial roles in a …
hallmarks of Alzheimer’s disease (AD) and are thought to play crucial roles in a …
Invasiveness, biology, ecology, and management of the fall armyworm, Spodoptera frugiperda
The fall armyworm (FAW), Spodoptera frugiperda (JE Smith, 1797), is a serious pest of
several crops, particularly maize and other cereals. It has long been known as a pest in the …
several crops, particularly maize and other cereals. It has long been known as a pest in the …
Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
JC Rojas, A Karydas, J Bang, RM Tsai… - Annals of clinical …, 2016 - Wiley Online Library
Objective Blood‐based biomarkers for neurodegenerative conditions could improve diagnosis
and treatment development. Neurofilament light chain (NfL), a marker of axonal injury, is …
and treatment development. Neurofilament light chain (NfL), a marker of axonal injury, is …
Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue
JC Rojas, AK Bruchey, F Gonzalez-Lima - Progress in neurobiology, 2012 - Elsevier
This paper provides the first review of the memory-enhancing and neuroprotective metabolic
mechanisms of action of methylene blue in vivo. These mechanisms have important …
mechanisms of action of methylene blue in vivo. These mechanisms have important …
Neurological and psychological applications of transcranial lasers and LEDs
JC Rojas, F Gonzalez-Lima - Biochemical pharmacology, 2013 - Elsevier
Transcranial brain stimulation with low-level light/laser therapy (LLLT) is the use of directional
low-power and high-fluency monochromatic or quasimonochromatic light from lasers or …
low-power and high-fluency monochromatic or quasimonochromatic light from lasers or …